Get updates on COVID-19 research at COVID-19 Resource
Crop Biotech Update

Getting a Biotech Crop to Market

November 11, 2011
Agribusiness consultant Philips McDougal reported the results of a research survey on the cost of marketing a biotech crop. It  showed that the cost of discovery, development and authorization of a new plant biotechnology trait introduced between 2008 and 2012 is US$136 million. The survey conducted in September 2011 was based on the information provided by leading major biotech crop developers BASF, Bayer CropScience, Dow AgroSciences, DuPont/Pioneer Hi-Bred, Monsanto and Syngenta AG. Biotech crops which have been commercialized in two countries and import approvals from at least five countries were considered. The Report also showed that:
  • the time from the initiation of a discovery project to commercial launch is 13.1 years on average for all relevant crops;
  • the time associated with registration and regulatory affairs is increasing from a mean of 3.7 years for an event introduced before 2002, to the current (2011) estimated 5.5 years;
  • regulatory science, registration and regulatory affairs accounts for the longest phase in product development, estimated at 36.7 percent of total time involved; and
  • the trend in the number of units (candidate genes, constructs or genetic events) being screened in order to develop one trait is increasing.
The original news can be seen at